While several predictors of an early and sustained response can be identified in the treatment of chronic hepatitis B, no consistently demonstrable predictors of response exist for chronic hepatitis C. As such, guidelines for the treatment of chronic hepatitis C are more complex than those for hepatitis B. The treatment options for chronic hepatitis B and C are outlined and there is speculation...

Liver disease has a worldwide distribution.(1,2) Hepatitis C virus (HCV) infection is a leading cause of chronic hepatitis and primary hepatocellular carcinoma in most parts of the world. In the developing countries of Asia and Africa, though hepatitis B virus (HBV) infection is the commonest cause of chronic liver disease, HCV is fast evolving as an equally important infection among these popu...

conclusions our study suggested that the prevalence rate of hepatitis c virus is below 1% in the general population of mashhad. results in this study the overall seroprevalence of hepatitis c was founded to be 0.2% by using elisa method. however, the overall hepatitis c virus infection prevalence was found to be 0.13% with rt-pcr method. patients and methods three thousand, eight hundred and se...

Nonalcoholic fatty liver disease (NAFLD) includes a wide spectrum of histological conditions, extending from simple steatosis to end-stage liver failure. The aim of this study was to examine the prevalence of NAFLD and its associations in chronic hepatitis B and C patients. Methods. We included all patients diagnosed with chronic hepatitis B and C who underwent a liver biopsy between January 20...

background: with respect to the importance of hepatitis a in patients with chronic liver disease, current study was conducted with the aim of determining the prevalence of previous hepatitis a infection in hepatitis b virus carriers with different stages of liver disease. materials and methods: this was a cross sectional study. 283 hbsag positive subjects (including 118 inactive carriers, 144 p...

grading of activity in chronic hepatitis C. METAVIR Cooperative Study Group. Hepatology 1996; 24:289–93. 8. Benhamou Y, Bochet M, Di Martino V, et al. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. Multivirc Group. Hepatology 1999; 30:1054–8. 9. Hadler SC, Judson FN, O’Malley PM, et al. Outcome of hepatitis B virus infection in homosexual m...

BACKGROUND A national survey for chronic hepatitis C has not been performed in Denmark and the prevalence is unknown. Our aim was to estimate the prevalence of chronic hepatitis C from public registers and the proportion of these patients who received specialized healthcare. METHODS Patients with a diagnosis of chronic hepatitis C were identified from four national registers: a laboratory reg...

Co infection with hepatitis C virus and hepatitis D virus (HDV) is less common than that with HIV and HCV, although more attention has been given to HCV co infection as a result of its higher frequency of chronic disease. The present investigation was attempted to determine the exact prevalence of hepatitis B virus (HBV), hepatitis C virus (HCV) and hepatitis D virus (HDV) infection among liver...

Within the last few decades, the incidence and prevalence of both hepatitis B and C infections have decreased among kidney disease patients. Significant advances have been made in the prevention of hepatitis B and C virus transmission in these high-risk populations; however, the transmission risk is still not negligible. Viral hepatitis infections represent a significant problem among kidney di...

alpha-interferon therapy has been approved for treatment of chronic hepatitis c and b. candidates for treatment are patients with well-compensated liver disease and histologic evidences of chronic hepatitis who have demonstrated abnormal aminotransferase levels for more than 6 months. from 30 patients with chronic hepatitis with diseases prolonged more than 6 months, we selected only 16 patient...